In the last 12 months, insiders at ZyVersa Therapeutics, Inc. ($ZVSA) filed 15 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
ZyVersa Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- SAPIRSTEIN JAMES (Director) — 2 transactions totaling $0
- Wolfe Peter (Chief Financial Officer) — 2 transactions totaling $0
- Glover Stephen C. (Chief Executive Officer) — 2 transactions totaling $0
- Cashmere Karen A. (Director) — 1 transaction totaling $0
- Freitag Gregory Gene (Director) — 2 transactions totaling $0
View all SEC Filings for ZyVersa Therapeutics, Inc. (ZVSA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| July 11, 2025 | Cashmere Karen A. | Chief Commercial Officer | A | Stock Options | 48100 | $0.00 | 48,100.0000 | 2,568,191 | 9999.99% | 1.87% |
| July 11, 2025 | Freitag Gregory Gene | Director | A | Stock Options | 11066 | $0.00 | 11,066.0000 | 2,568,191 | 9999.99% | 0.43% |
| July 11, 2025 | Glover Stephen C. | Chief Executive Officer | A | Stock Options | 136900 | $0.00 | 136,900.0000 | 2,568,191 | 9999.99% | 5.33% |
| July 11, 2025 | Finizio Robert G | Director | A | Stock Options | 11066 | $0.00 | 11,066.0000 | 2,568,191 | 9999.99% | 0.43% |
| July 11, 2025 | Wolfe Peter | Chief Financial Officer | A | Stock Options | 60100 | $0.00 | 60,100.0000 | 2,568,191 | 9999.99% | 2.34% |
| July 11, 2025 | Guzman Pablo A. | Chief Medical Officer | A | Stock Options | 48900 | $0.00 | 48,900.0000 | 2,568,191 | 9999.99% | 1.90% |
| July 11, 2025 | Park Min-Chul | Director | A | Stock Options | 11066 | $0.00 | 11,066.0000 | 2,568,191 | 9999.99% | 0.43% |
| July 11, 2025 | SAPIRSTEIN JAMES | Director | A | Stock Options | 11066 | $0.00 | 11,066.0000 | 2,568,191 | 9999.99% | 0.43% |
| May 24, 2023 | Cashmere Karen A. | Director | A | Stock Options | 572 | $0.00 | 572.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Wolfe Peter | Chief Financial Officer | A | Stock Options | 715 | $0.00 | 715.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Glover Stephen C. | Chief Executive Officer | A | Stock Options | 1627 | $0.00 | 1,627.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Park Min-Chul | Director | A | Stock Options | 132 | $0.00 | 132.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Freitag Gregory Gene | Director | A | Stock Options | 132 | $0.00 | 132.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | SAPIRSTEIN JAMES | Director | A | Stock Options | 132 | $0.00 | 132.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Finizio Robert G | Director | A | Stock Options | 132 | $0.00 | 132.0000 | 0 | 9999.99% | 0.00% |